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CHAPTER ONE 
1.1. Introduction 
Since human orthotopic allotransplantation of the heart became a reality 
in 1968, clinical experience has consolidated the knowledge obtained ex-
perimentally in the previous period. According to some investigators no-
thing more than this has been achieved. In an early comment on clinical 
heart transplantation, Dempster et a!. ( 43) declared "Nothing new was 
proved by the incursion into human heart transplantation". The same au-
thors continued "None-the-less experimental work must continue in the 
quite relentless way it has in the past". 
Experimental orthotopic heart transplantation. 
Many essential steps were clarified by experimental work before the first 
human allotransplantation of the heart was performed: the development 
of an adequate surgical technique for orthotopic heart transplantation 
(7 8), the demonstration of near normal function of the transplant despite 
denervation (35 ,44,45 ,79), and the clinical diagnosis and histopathology 
of acute transplant rejection (68,76,77 ,80). Acute rejection after one week 
is the ultimate fate of the cardiac allograft if donor and recipient are un-
related and no immunosuppressive drugs are given to the recipient. 
Also a limited experience was gained concerning the effectiveness of im-
munosuppressive drugs on the survival of the heart transplant, and it was 
demonstrated that recovery from acute rejection was possible by the timely 
use of such therapy. Small areas of scar tissue marked the location of tissue 
destruction that had occurred due to the damage of the capillaries 
venules and myocytolysis. These scar tissue formations occur because the 
parenchymal cells of the heart are unable to regenerate (47, 68). 
Lower et a!. (79 ,81) described the longest survival of 18 months for a heart 
transplant in a dog given immunosuppressive therapy in the form of 
azathioprine and methylprednisolone. These workers (81) however expres-
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sed their concern about the microscopic findings of the vascular lesions 
which they observed in the transplant. They wrote "Such arterial lesions 
appear to represent a form of chronic rejection which may in the early 
stages go undetected by the electrocardiogram". This and other experience 
(13,22,23,31,55,67 .) with the use of immunosuppressive drugs in dogs and 
calves after orthotopic allotransplantation of the heart, did not give much 
hope for prolonged survival following clinical heart transplantation. 
Clinical orthotopic heart transplantation. 
The anticipation of better results in human heart transplantation was based 
on the previous experience and improvement in clinical renal transplant-
ation (6). Also, the protocols for immunosuppressive treatment were 
mainly based on the experience obtained in human cadaver renal trans-
plantation (6, 37). 
In December 1967, eighteen days after a heart transplant in Cape Town (5) 
the first cardiac transplant patient died. In 1968 and in the following years 
the world was confronted with a wave of clinical heart transplants, the 
results of wich sometimes gave rise to severe criticism (43). 
The results obtained in experimental work before 1968 could now be 
confirmed in clinical practice. For example, the surgical technique of Lower 
eta!. (78), with a single modification (4, 38), was used by all surgical teams 
and turned out not to be a major cause of hospital mortality. 
The essential element of Lower's technique is to excise the heart of the 
recipient by a midatrial incision and to use these atrial cuffs for the venous 
anastomoses. This avoids the need of making multiple venous anastomoses 
of both caval veins to the right atrium and the separate lung veins to the 
left atrium. 
Barnard and Cooley (4, 38) modified the technique by dividing and ligating 
the superior caval vein of the donor heart. The right atrium of the donor 
heart was opened through an incision starting at the inferior caval vein up 
into the atrial wall away from the area of the sinus node and its arterial 
supply. This modification minimized the risk of direct injury to the sinus 
node. 
When prophylactic immunosuppressive therapy prevented the onset of the 
rejection process, adequate function of the heart transplant was achieved 
both subjectively and objectively (8, 50, 54, 106, 109.). The experimentally 
acquired criteria for the diagnosis and the characteristic histopathology of 
acute rejection were clinically confirmed. 
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Just as in experimental animals, the acute rejection process was the major 
cause of the early death in patients after heart transplantation. In spite of 
intensive immunosuppressive therapy, this process turned out to be largely 
irreversible. Besides, the high dosage of immunosuppressive drugs was often 
the cause of a fatal intercurrent infection (24, 100). 
Initially the long term results in patients after heart transplantation, were 
comparable to the results of previous experimental work. The first 
published results clearly demonstrated this. By the end of 1968, all over 
the world, 65 transplants had been registered. At the time of the report 
in October of that year, 33 patients had already died (53). Even at the 
Stanford University Clinic in Palo Alto, where Shumway and his co-workers 
had applied themselves with utmost care to the experimental and clinical 
problems of heart transplantation, there was a mortality of 78% in the first 
year following transplantation (50). For one surgeon this was enough then 
to state "I reserve the right to change tomorrow, but I am proud of our 
restraint in not performing heart transplantations yesterday" (57). 
However disappointing these initial results, they were better than what 
could have been expected on the basis of previous experimental work. 
In spite of this high early mortality in the first year after transplantation 
the Palo Alto group achieved a one year survival rate of 22% in their pa-
tients (50). A similar percentage of one year survival had never been 
achieved in any experimental research. In the following years, it proved 
possible to improve the results to the same level of success as in clinical 
renal transplantation with unrelated donors. For example, in 60 patients 
who underwent heart transplantation since the end of 1973, the survival at 
one, two and three years was 66,63 and 58% respectively (7). 
A number of factors have played a role here (49). This included an in-
creased experience in the use of immunosuppressive drugs and the 
verification of the effect of this therapy on acute rejection by means of 
transvenous myocardial biopsy (26, 27, 28). Also, anticoagulant therapy 
and a low cholesterol diet with strict caloric limitation was claimed to be 
used with some success against the process of chronic rejection (77). 
So far, human heart transplantation has provided no firm data concerning 
the significance of tissue typing in the outcome of these transplants with 
inevitably unrelated donors (I 08). 
The results from research in clinical renal transplantation (93) and from 
experimental work indicate that previous blood transfusions donated to 
the recipient can have a favourable influence on the kidney transplant 
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prognosis. The extent, to which blood transfusions have influenced the 
results of heart transplantation is uncertain, but this has been mentioned 
in literature as a possible relevant factor (39, 58). 
Chronic cardiac allograft rejection was the next major obstacle in clinical 
transplantation and limited to a great extent the possibility of achieving 
a considerable prolongation of life after transplantation ( 48, 51, 116). The 
progressive course of this type of rejection poses great diagnostic problems. 
This type of rejection results in a syndrome of severe coronary artery 
disease which, for most patients, was identical to the original disease 
necessitating heart transplantation. 
After ten years of clinical heart transplantation, only 77 (23%) out of 
338 patients, operated upon in this period are still alive (107). These 
figures clearly demonstrate that acute and chronic rejection have remained 
at least partially unsolved problems. A continuation of experimental work 
was therefore necessary, even during the clinical phase of heart 
transplantation. 
The continuation of experimental orthotopic heart transplantation. 
In his thesis Jongsma (63) reviewed the results of orthotopic heart 
transplantation in various laboratories. Although most of the investigators 
used dogs, others used pigs, calves or primates. The surgery was carried 
out with the help of extra corporeal circulation in larger experimental 
animals and with deep hypothermia in smaller animals (20, 21, 31, 42, 65, 
66.). It is not surprising that for many research workers the management 
of the surgical technique was of first priority as many attempts at 
orthotopic transplantation resulted in a too high operative mortality 
(56, 71, 77, 87, 88, 89, 105, 118.). The fact that very few laboratories 
were provided with an orthotopic heart transplant model for further 
research, contributed to this lack of success. 
It is easy to understand that most of the experimental work during the 
phase of human heart transplantation was clinically oriented. The clinician 
was confronted with the actual problems of the cardiac transplant patient. 
Methods had to be developed for early and accurate diagnosis of rejection, 
and for the optimal treatment with the available immunosuppressive drugs. 
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The clinical and histopathological features of long term survivors after 
heart transplantation had to be defined. Under pressure of these clinical 
questions, there was limited progress in fundamental research, oriented 
towards the basic immunological problems of heart transplantation. In 
practice this meant that there was little opportunity for immunologists to 
study specific questions in a model of orthotopic heart transplantation in 
experimental animals. 
Therefore, there is a clear need for the clinical surgeon, who is able to 
perform orthotopic heart transplantation in experimental animals, to work 
together with immunologists to develop their own models for fundamental 
research into transplantation. Such a cooperation between the surgeon and 
the immunologist in the study of heart transplantation forms the basis of 
the experiments in heart transplantation that will be described in the 
following chapters. 
1.2. Rationale of the study 
The preference for the canine orthotopic heart transplant model used in 
this study, is based on the work of Jongsma (63), who compared the 
orthotopic with the heterotopic model of heart transplantation. Jongsma 
concluded that the impaired coronary circulation in the heterotopic 
position caused extra ischemic damage to the graft and resulted in a specific 
rejection process characterized by the predominance of necrotizing arteritis 
and infarction necrosis. 
Model of acute rejection. 
In 1961 Lower was the first to publish a reproducable surgical technique 
of orthotopic heart transplantation in dogs. Using unrelated donor-recipient 
combinations and without the use of immunosuppressive drugs, he 
provided a classical model for acute rejection of an orthotopic heart 
transplant in an experimental animal. Twenty dogs died from acute 
rejection with a mean survival time of one week and a range of 4 to 21 
days. This was recognized as a great achievement by everyone familiar with 
the history of heart transplantation. This history of heart transplantation 
has been reviewed by Hairston (52) and since then by many other 
investigators. 
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Jongsma (63) confirmed these observations under the same conditions in 
13 dogs after orthotopic cardiac allografting. He achieved a mean survival 
time of 9.6 days with a range of 5 to 15 days. The microscopic features 
confirmed the classical picture of acute allograft rejection. This histological 
picture was characterized by: 
a) an infiltration of mononuclear cells 
b) rupture of capillaries and venules 
c) myocytolysis of myocardial fibres and eventually 
d) a necrotizing arteritis of small arteries. 
Thus, fundamental research was provided with a classical model of acute 
rejection of an orthotopic canine cardiac allograft. 
However, the importance of tissue typing in unrelated donor-recipient com-
binations still remains to be investigated in this preparation. Neither has 
the effect of the transfusion of homologous or so called third party blood, 
been examined in this model of orthotopic heart transplantation. 
Model of chronic rejection.. 
The results obtained after attempts to construct a model for a slowly 
developing rejection process, or chronic rejection of an orthotopic canine 
allograft are less clear and very difficult to delineate. 
A clinical approach is usually described in the litterature to achieve a 
prolongation of graft survival in experimental animals. To accomplish this 
goal, drugs like corticosteroids, azathioprine, methotrexate and anti-
lymphocytic globulin are given to the recipients. Additional dosages of 
these drugs are given at times of an apparent acute rejection episode 
(13, 22, 23, 31, 67, 79). This clinical approach results in only a small 
number oflong term survivors, especially when one considers the large 
numbers of experiments that have been performed. In addition, the results 
are not easily reproducible and the non-specific suppression of the immune 
response of the host by these drugs causes a reduction in resistance to 
infection. A valid interpretation of the results is also made more difficult 
in most cases by the administration of a high dose of immunosuppressive 
drugs which very often results in a complicated picture of drug 
intoxication. 
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To elucidate a systematic approach in the use of immunosuppressive drugs, 
the work Jongsma reported should be mentioned (63). He published 
a systematic use of immunosuppressive drugs in 13 dogs after orthotopic 
heart transplantation with unrelated donors. 
Drugs were given according to the following schedule: 
Initially high doses of methyl prednison (I Omg/kg bodyweight) and 
azathioprine (!Omg/kg bodyweight) were given, starting at surgery and on 
the first postoperative day respectively. The dosage was tapered off during 
the following days until a daily maintenance dose of azathioprine of 
3 mg/kg bodyweight and prednison of I mg/kg bodyweight. On the 7th 
postoperative day the whole schedule was repeated and again gradually 
diminished to the maintenance dose. From that day on (the 12th day), 
regardless the occurrence of an acute rejection process, the maintenance 
dose was continued to the end of the experiment. This fixed schedule of 
immunosuppression resulted in: 
a) a wide range of survival time of the cardiac allografts, from 7 to 282 
days with a mean survival time of 64 days; 
b) the occurrence of a large number of infections, 4 out of 13 animals; 
c) the occurrence of drug intoxication in 9 out of 13 experimental 
animals. 
In summary, neither the clinical use nor the systematic use of 
immunosuppressive drugs in orthotopic heart transplantation in unrelated 
dogs had lead to a reproducible and predictable long term survival. The 
frequent occurrence of infections and drug intoxication in the experimental 
animals hampered a proper judgement and a mutual comparison of the results. 
As a result of these unpredictable factors it is unlikely that orthotopic heart 
transplantation in unrelated dogs followed by the use of presently available 
immunosuppressive drugs, will result in a suitable basic model for chronic 
rejection. 
Again it should be stated that the influence of tissue typing and the 
administration of homologous blood transfusions during transplant 
surgery or thereafter on graft prognosis was not taken into account in any 
of these investigations on long term survival. 
From this discussion on the development of a model for chronic rejection 
of the orthotopic canine cardiac allograft, the emerging alternatives are: 
17 
I) To prolong graft survival without the detrimental effects on the 
recipient by the use of immunosuppressive drugs. As will be 
demonstrated, DLA matching served this purpose in the present study. 
In the laboratory for experimental surgery of the Erasmus University 
in Rotterdam, much work has been done demonstrating the existence 
in dogs of a main histocompatibility complex, the DLA complex. It is 
analogous to the human HLA complex. For an increasing number of 
organs, prospective tissue typing for this DLA complex proved to be of 
importance for graft survival in beagle siblings. Differences in graft 
survival times were even demonstrated without the use of immuno-
suppressive drugs (122). 
2. To develop a surgical technique of orthotopic cardiac allografting in 
dogs without the need for homologous donorblood. 
In the preceding pages it was stated that all clinical and experimental 
investigation on orthotopic heart transplantation included the use of 
homologous donor blood. In the past the reason has been that surgery 
of this kind necessitated blood transfusions because of the use of extra-
corporeal circulation, heparinization of the recipient and the post-
operative blood loss. 
In contrast to this, great restraint has been exercised in kidney trans-
plantation in the use of pretransplant blood transfusions in order to 
minimize the risk of an immunization of the recipients against donor 
antigens. This transfusion policy in clinical as well in experimental kid-
ney transplantation is at present widely debated (90, 103). Clinical and 
experimental results are now available which show a benificial effect of 
prior blood transfusions on kidney graft survival. 
In clinical heart transplantation Coulson et a!. (39) reported that pa-
tients who had previous heart surgery on cardio pulmonary bypass 
appeared to fare better than those who did not have that type of surgery 
in the past. Further discussion on this aspect of the use of homologous 
donor blood is presented in the last chapter of this thesis. 
Thus far, no information has been reported on the effect ofhomologous 
donor blood on graft survival in orthotopic canine cardiac allografting. 
1.3. Objectives of the present study 
In accordance with the two alternatives discussed in the preceding pages the 
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aim of the study was twofold and dictated the design of the first and second 
experiment. 
First objective and first experiment: 
The first objective was to develop a model of chronic rejection of an 
orthotopic canine cardiac allograft using DLA-identical beagle littermates 
without immunosuppressive drugs. Thus, the detrimental effects of immuno-
suppressive drugs were to be specifically excluded. 
Second objective and second experiment: 
The second objective was to design and test a surgical technique of ortho-
topic canine cardiac transplantation without the need for homologous 
donor blood. 
It should be noted that at the time the first experiment was performed, it 
was believed impossible to meet the second objective with the current state 
of surgical technique. Therefore the results of the second experiment could 
not be included as a prerequisite in formulating the first objective. 
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CHAPTER TWO 
MATERIAL AND METHODS 
2.1. Animals. 
In the first experiment prospectively tissue typed adult littermate beagles 
from an out bred colony were used as heart donor and recipient. 
The beagles were obtained from "the Centraal Proefdieren Bedrijf T.N.O." 
(Zeist, the Netherlands, Dr. J. van Vliet) and from our own colony. 
The weights of the recipients ranged from 9.4 kg to 19.5 kg (mean 13.6 
kg). 
Fresh heparinized blood for pump-priming and citra ted blood for post-
operative blood transfusion were collected from mongrel dogs. 
In the second experiment both recipient and donor dogs were mongrels, 
unrelated to each other and matched only for size and weight. The mean 
body weight of the 10 successfully transplanted mongrels was 11.5 kilogram. 
In accordance with the aim of this experiment, no homologous third party 
donor blood was used, neither for pump-priming nor for postoperative 
blood transfusion. 
2.2. Tissue typing. 
Prospective tissue typing was performed in the first experiment in which 
littermates were used as heart donor and recipient. 
The microcytotoxicity test of Kissmeyer-Nielsen, modified by Van Rood 
eta!. (10 I), was applied to test dog peripheral lymphocytes. The product-
ion and evaluation of dog allolymphocytotoxins for donor selection have 
been reported by Vriesendorp et a!. in more detail elsewhere (119, 121 ). 
2.3. Design of the first experiment. 
Based on identity or nonidentity for the serological defined (SD) antigens 
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two groups of beagle littermate pairs were formed for this first experiment. 
In group one heart donor and recipient were DLA-identical beagle litter-
mates. 
In group two heart donor and recipient were DLA-nonidentical beagle litter-
mates and served as a control. 
None of the recipients from these two experimental groups received any 
specific type of immunosuppressive treatment before, during, or at any 
time after orthotopic cardiac transplantation. 
2.4. Surgical procedure. 
The surgical technique for orthotopic cardiac allografting was originally 
described by Lower eta!. (78) and has been reviewed in great detail by 
Caves and Dong (25 ). This surgical technique was adopted for this study as 
the method of choice. Our surgical procedure and the use of a Dreissen rol-
ler pump with a Q 130 Temptrol disposable bubble oxygenator has been 
reported by Jongsma (63). 
In the first experiment, total pump-priming consisted of fresh heparinized 
blood and postoperative blood transfusions were given with fresh ACD 
blood. The blood was collected from mongrels just prior to surgery. 
For the second experiment homologous third party donor blood was not 
used. 
Instead the priming volume of the pump consisted of 400 ml 
HAEMACCEL ® (Behring) only. At the conclusion of extra corporeal 
support the total priming volume of the pump was returned to the recipient. 
The setup of the autotransfusion system after completion of orthotopic 
cardiac transplantation is illustrated in Fig. I. Before closure of the chest 
an infusion line for continuous acid-citrate-dextrose 16% (ACD) drip was 
positioned inside the pleural space where the citrate mixed with the blood 
still leaking in the pleural cavities. 
This ACD blood was collected from a single thick chestdrain by intermit-
tent manual suction using a syringe. The collected blood was then centrifu-
gated. 
After discarding the hemolytic plasma, the resulting packed cells were 
diluted with saline and returned to the animal by intravenous infusion. 
Depending on the amount of citrate used, this was counteracted by intra-
venous infusion of calciumchloride. The hemolytic plasma loss was sub-
stituted with haemaccel. 
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Fig. 1: The postoperative setup of the auto transfusion system after orthotopic canine cardiac 
transplantation. 
2.5. Postoperative management. 
Approximately 6 hours after surgery the dogs were fully awake and active 
and were returned to their cages. 
On the first postoperative day the animals were allowed unrestricted fluid 
intake. From the second day on they also were fed solid food. 
Antibiotics were given intramuscularly: on day 0,3 doses of 1 million units 
penicillin and 0.5 g streptomycin; on days 1 to 6, 2 doses of 1 million 
units penicillin and 0.5 g streptomycin daily. 
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2.6. Exclusions. 
All dogs, failing to survive the surgical procedure or immediate postoperative 
period after transplantation or those dogs ultimately dying for reasons 
other than rejection as a major cause, were excluded from this study. 
Their causes of death are discussed in more detail in the next chapter. 
2.7. Survival time. 
In orthotopic cardiac transplantation graft survival time coincides with the 
survival time of the animal. 
Four dogs from the first experiment were sacrificed by an overdose of 
Penthotal because these dogs finally manifested a severe end-stage of the 
rejection process and were unable to support or to feed themselves. 
2.8. Electrocardiographic studies. 
Daily electrocardiographic limb lead tracings were taken on each dog after 
transplantation. 
A Hewlett Packed ECG recorder no. 1511 A (monochannel), recorder speed 
of 25 mm/sec. (voltage I mY= 10 mm), was used throughout this study 
and calibrations were made prior to recording. 
Because the dogs mediastinum is a loose structure, special attention was paid 
in keeping each animal in a right lateral recumbent position during ECG 
recording. 
The initial postoperative electrocardiogram was considered a base-line stan-
dard in each recipient. Peak-to-peak QRS voltage in lead II and cardiac 
rhythm were determined. 
2.9. Histopathology. 
At the time of recipient death, the thoracic and abdominal contents were 
examined grossly. 
Fresh representative sections of the graft were preserved in 4 per cent 
phosphate buffered formalin (pH 7.0) and imbedded in a paraffin-para-
plast beewax mixture. Sections were cut 5 to 7 micron thick and stained 
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with hematoxilin-azophloxin-saffron (HAS) for subsequent histologic 
examination. 
The microscopic findings of graft rejection were graded from 0 (minimal 
change) to 4 (extensive change) in a semi- quantitative manner. 
2.1 0. Hematology. 
Hematological changes were evaluated in the second experiment, following 
orthotopic canine cardiac allotransplantation, using total hemodilution and 
postoperative autotransfusion. Bloodsamples were taken to determine 
hemoglobin concentration, hematocrit, the number of platelets, the 
fibrinogen concentration in the plasma, and the appearance of fibrinogen 
degeneration products. The platelets were counted with the Coulter counter 
model C. 
The fibrinogen concentration was measured according to Clauss (34). 
To determine the presence of fibrinogen degeneration products the techni-
que of Laurell (74) was employed. 
These samples were collected before surgery, four hours after transplantation, 
and the first day, the second day and one week after transplantation. 
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CHAPTER THREE 
RESULTS 
3.1. First experiment. 
A total of 31 orthotopic cardiac allotransplantations were performed 
among prospectively tissue typed beagle littermates. Cold ischaemic times 
for the grafts during transplant surgery ranged from 35 to 55 minutes. The 
amount of postoperative blood transfusioned ranged from 250 to 1200 mi. 
Exclusions. 
In total 15 animals were eventually excluded from the study. 
Surgical mortality resulted in the exclusion for further analysis of 12 
animals (39%). 
Uncontrollable leakage from the suture line at the level of the friable supra-
valvular aortic tissue in the immediate postoperative period caused the 
highest early mortality rate of 29% (9 animals). 
One animal died because of a technical failure in the management of extra 
corporeal circulation. As a result the dog became decerebrated and 
subsequently died. 
Complete heartblock was the cause of death in two animals (6%) and both 
died on the second postoperative day. The two dogs were DLA-nonident-
ical to their heart donors. Postmortem histopathological examination of the 
grafts from the recipients did not reveal signs of rejection. The two beagles 
were excluded from the study. 
Another two beagles, both DLA-identical to their littermate heart donor, died 
from bilateral pneumonia on the 7th and 13th postoperative day respect-
ively. No clinical and histopathological signs of rejection were observed. 
Both animals were excluded from the study for fmther analysis. 
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Perforation of the aortic suture line caused sudden death in one animal on 
the tenth postoperative day. Donor and recipient were tissue typed as DLA-
identical pair. Also in this case, postmortem histopathological examination 
of the graft, showed no signs of rejection and only an area of local tissue 
necrosis was seen at the point of the aortic perforation. This animal was also 
excluded from the study. 
Survival times (Table I). 
A total of 16 dogs, 8 in group one and 8 in group two, recovered from 
transplant surgery, but all these animals later died from the rejection 
response as the major cause of death. 
Table 1 
First experiment. Orthotopic cardiac allografting of beagle to littermate. 
No immunosuppression. 
DLA Typing: 
Survival time, days: 
M.S.T., days: 
M.S.T. mean survival time 
( ) number of animals 
(S) = sacrificed 
GROUP ONE 
Identical (8) 
247(S), 164(S), 132(S), 
80,47,44,38,21 
96,6* 
* P < 0.01 (two-sided Wilcoxon test). 
28 
GROUP TWO 
Non-identical (8) 
48,44(S), 17, 14, 11, 11, 
10,9. 
20,5 
Group one. 
The survival times of 8 animals after orthotopic cardiac allotransplantation 
in this group of DLA-identical donor-recipient beagle littermate pairs 
were 247, 164, 132, 80, 47, 44,38 and 21 days respectively. 
The three longest surviving animals were sacrificed because, as has been 
stated in the previous chapter, they developed a severe end-stage of the 
rejection process and were unable to support or to feed themselves. 
Mean survival time of the transplanted beagles in this group was 96.6 days, 
with a range of 21 to 24 7 days. 
Group two. 
In this group of 8 beagles after orthotopic cardiac allografting between 
DLA-nonidentical donor-recipient littermate pairs, the survival times were 
respectively 48, 44, 17, 14, 11, 11, 10 and 9 days. 
Also in this group one animal, the second longest survivor, was sacrificed 
at day 44 because it developed a severe end-stage of the rejection process. 
Mean survival time of the transplanted animals in this group was 20.5 days, 
with a range of 9 to 48 days. 
The differences between the mean survival times observed in group one and 
group two are statistically significant (P < 0.01 in two-side-test. Wilcoxon 
test). 
Clinical signs of rejection. 
While in the first group 5 out of 8 animals developed ascites during the 
course of their protracted survival, only two long surviving dogs in group two 
demonstrated this clinical feature, which is illustrated in Fig. 2. 
In the short term surviving dogs, dying of acute rejection, the first clinical 
signs observed were lethargia and anorexia. 
If no signs of rejection were present, the dogs looked healthy and showed 
normal activities (Fig. 3). 
Electrocardiography. 
In the immediate post-transplant period after electrical or spontaneous 
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defibrillation, all hearts of the surviving dogs in group one and group two 
demonstrated normal sinus rhytm. 
Occasionally arrhythmias were present during the first operative day and 
disappeared by the second or third day. These arrhythmias did not produce 
obvious alterations in the clinical status of the animals. 
An example of arrhythmias in the early postoperative period is presented 
in Fig. SA. This arrhythmia disappeared on the second postoperative day 
(Fig. SB). 
The occurrence of electrocardiographic abnormalities, reflects the patho-
logical changes in the transplanted heart during the course of the rejection 
process. 
Two changes which correlate well with the histological findings of acute 
rejection are a decrease in the QRS voltage (Fig. 4 ), seen best in the R wave 
of limb lead II, and the late occurrence of arrhythmias (80). 
In both groups one and two, the time of first appearance and the nature of 
these electrocardiographic changes were recorded and also the time interval 
in days between first recording of the electrocardiographic abnormality and 
the time of death of the experimental animal (Table 2). 
Table 2 
First experiment. Recording of first appearance of electrocardiographic changes. 
No. of dogs Decrease in QRS voltage Arrhythmias A.T.I. (days) 
Group one: 8 
Day of first 
appearance: 
Group two: 8 
Day of first 
appearance: 
3 
13,20,28 
5 
4,5,5, 7,9 
5 38.3 
34, 62, 83, 
93,131 range: 9-115 
3 9.9 
9,15,24 range: 4- 36 
A.T .1.: Average Time Interval in days between first recording of the electrocardiographic 
abnormality and the time of death of the experimental animal. 
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Fig. 2: Dog presenting ascitis 142 days after orthotopic cardiac allografting. 
Fig. 3: Dog presenting no clinical signs of rejection eight weeks after orthotopic cardiac allo-
transplantation. 
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Fig. 4: Post-operative E.C.G. recording inacute rejection. Dog BD982. 
In group one the daily ECG recordings of the three shortest surviving dogs, 
after orthotopic cardiac allotransplantation from a DLA-identicallitterrnate 
donor, demonstrated a persistent decrease in the QRS voltage, starting at 
day 13, 20 and 28 respectively. 
The ECG recording of the other 5 dogs showed arrhythmias as the first 
electrocardiographic abnormality which started at day 34, 62, 83, 93 and 
13 I respectively and persisted thereafter. 
The average time interval between first recordings of the ECG changes and 
the times of death of the dogs in this first group was 38 3 days with a range 
of 9 to II 5 days. 
The first appearance of an arrhythmia in a long surviving dog is illustrated in 
Fig. 5C. 
In group two a decrease in QRS voltage was recorded as the first electro-
cardiographic change in 5 dogs, starting respectively at day 4, 5, 5, 7 and 9. 
The three longest surviving dogs in this second group demonstrated arrhyth-
mias as the first electrocardiographic abnormality on their daily ECG recor-
ding at respectively day 9, 15 and 24. 
In this group of 8 beagles after cardiac allografting between DLA-nonident-
icallittermate pairs, the average time interval between first recordings of 
ECG changes and the times of death of the dogs amounted to 9.9 days, with 
a range of 4 to 36 days. 
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ence of arrhythmia during chronic rejection. 
Fig. 5: Post-operative E.C.G. recordings. 
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Histopathology. 
The general autopsy findings correlated well with the clinical course of the 
rejection process in both groups one and two. 
At autopsy the clinical signs of left and right sided congestive heart failure, 
or a combination of both, as observed during the course of the rejection 
process, paralleled the findings of various amounts of pleural effusion and 
of free fluid in the abdomen. The amount of fluid was directly proportional 
to the duration of the rejection process and in the two extreme cases 
amounted to over 1300 ml of pleural effusion and more than 5000 ml of 
free fluid in the ab•\ominal cavity. In one of these extreme cases the extrem-
ities of the animal showed severe edema. 
The degree of congestion of the various organ systems appeared to be pro-
portional to the severity of left and right sided heart failure, as reflected by 
the amount of pleural and abdominal effusion. 
Graft findings. 
To illustrate the characteristic histopathological differences in the transplants 
between group one and group two, the most typical findings in one represent-
ative specimen of each group are described. 
Macroscopical features. 
Group one (dog BD 9173, survival time 132 days). 
The chest cavities contained a minimal amount of clear yellow fluid. 
In the abdomen 5000 ml free fluid was present. There were dense epicar-
dial adhesions to the left lung and the previously opened pericardium. The 
heart was enlarged and the walls of both ventricles were thickened. 
The color of the myocardium was normal. There was no myocardial 
hemorrhage and edema typical of acute myocardial rejection. The epicard-
ial surfaces showed only slight roughening and opacity. 
The heart cavities, opened along the lines of bloodflow, were filled with 
post-mortem clots not adhering to the endocardium. 
All suture lines were well healed and smooth. 
The four cardiac valves were remarkably deformed. The cusps were slightly 
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retracted and the free edges of the valves were rolled, thickened, and irreg-
ular. Both atrioventricular valves showed evidence of shortening and dis-
tortion of the chordae tendiniae. 
Group two (dog Bd 9118, survival time 10 days). 
There was 250 ml of clear yellow fluid present in the chest cavities and a 
minimal amount of fluid was present in the abdomen. 
There was evidence of a fibrinous pericarditis and an increased amount of 
fluid was present in the pericardia! cavity. The heart was enlarged and the 
myocardium edematous. 
After opening along the lines of bloodflow, the heart cavities were found to 
be filled with post-mortem clots not adhering to the endocardium. The 
myocardium was dusky red and felt rubbery. 
On the endocardial side of the myocardium many small, ill defined foci of 
hemorrhage were present. All suture lines were smooth. The heart valves 
appeared to be slightly edematous. 
Microscopical features. 
Group one (dog Bd 91 7 3, survival time 132 days). 
Within the myocardium there were only slight focal infiltrations of histio-
cytes and lymphocytes compared to the dogs in the other group. 
The small interstitial vessel walls were intact and the small arterioles diffusely 
demonstrated thickened, hyalinised walls. 
The myocardinm showed scattered areas of infarction necrosis, character-
ized by hyalinization of muscle fibres and a scarcity of cellular infiltrate. 
The most profound lesions were observed in the intramural and epicardial 
coronary arteries. The lumina of the arteries were extremely narrowed or 
obliterated, mainly because of an intense proliferation of intimal cells. 
Many intimal cells showed cytoplasmic vacuolization. The media and 
adventitia showed various amounts of fibrosis, often with total obliteration 
of muscle fibres. The infiltration of all layers of the vessel wall with lymph-
ocytes, plasma cells, histiocytes and an occasional granulocyte is a promi· 
nent feature. 
These changes, found to be typical for chronic rejection, will be indicated 
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as a chronic obliterative arteritis to distinguish these changes from the 
acute necrotizing arteritis found in the early phase of rejection. 
All valves showed extensive vascularisation and thickening. There was a 
scanty infiltration of mononuclear cells and deposition of collagen. 
The valves contained areas of very loose structures composed of fibrocytes. 
Group two (dog Bd 9118, survival time 10 days). 
The myocardium showed an extensive mononuclear cell infiltration. 
These cells, lymphocytes and blastlike lymphoid cells were mainly found 
around arteries and myocardial fibres. There was widespread congestion by 
intraluminal cell accumulation and focal rupture of the wall of small 
interstitial vessels was regularly seen. These ruptures explained the local 
hemorrhages into the surrounding tissue. 
There was extensive myocytolysis as characterised by multiple foci of 
shrinkage, fragmentation and disappearance of myocardial fibres in these 
areas infiltrated by mononuclear cells. 
The walls of small arteries and large arterioles demonstrated the features of 
necrotizing arteritis. There was infiltration with mononuclear cells and 
granulocytes, medial necrosis and swelling of the endothelium. 
All the valves were edematous and infiltrated by mononuclear cells. 
The macroscopical findings in the short term surviving dog suggest that 
heart failure primarily resulted from failure of the cardiac allograft as a 
pump. In the long term surviving dog, because the enormous amount of free 
fluid in the abdomen and the valvular lesions, it is likely that, apart from 
failure of the graft as a pump, the valvular lesions contributed to a great 
extent to the untimely death of the animal. 
The grading of the histopathological findings of the sixteen grafts included 
in this study is summarized in table 3 and 4. To minimize the risk of bias, 
a "blind" assessment technique of grading the microscopical features was 
used. This analysis was performed independently by a consultant histopa-
thologist. 
The microscopy slides were handed at random to this investigator, who had 
no prior knowlegde about the clinical course of each animal. 
The microscopical findings clearly demonstrate the virtual absence of a 
parenchymal type of rejection and instead the presence of major patholo-
gical lesions in the coronary arteries and the cardiac valves. All six dogs in 
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group one, surviving 44 days or longer, showed these features to a great 
extent, while similar lesions were absent in the two shorter surviving 
animals in this group. The major lesions in these last two grafts presented 
the features of parenchymal rejection as it is known in unmodified acute 
rejection, i.e. evidence of mononuclear cell infiltration, rupture of small 
interstitial vessels, myocytolysis and necrotizing arteritis. 
These lesions have been described in great detail by Jongsma (63). 
In the control group of eight DLA-nonidentical beagle littermates, only 
the two long term surviving animals of 44 and 48 days respectively, showed 
the changes found to be typical for chronic rejection and indicated as 
chronic obliterative arteritis. 
The Fig. 6, 7 and 8 illustrate the typical histopathological features of 
acute cardiac allograft rejection in dog BD 9118, surviving 10 days after 
surgery. 
The characteristic histopathological features of chronic cardiac allograft 
rejection are depicted in Fig. 9, 10, II and 12 as observed in dog BD 9172 
of group one; survival time 132 days. 
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w Table 3 
00 
Histopathology of cardiac allografts. Group one. 
DLA typing Identical 
Dog number B945 B958 BD9173 B983 BD92!9 BD9287 Bd9129 89148 
Survival time (days) 247 164 132 80 47 44 38 21 
MYOCARDIUM: mononuclear infiltrate 0 I I I I I 2 
myocytolysis 0 0 0 I I 0 2 
necrotizing arteritis 0 0 0 0 2 0 3 2 
focal necrosis 3 2 3 I 3 3 2 2 
rupture interstitial vessels 0 0 0 I I 0 2 0 
CORONARY ARTERIES: 
(medium size) necrotizing arteritis 0 0 0 0 2 0 3 2 
obliterative arteritis 4 3 4 2 3 3 0 0 
VALVES: edema 0 0 0 0 0 0 
mononuclear infiltrate I I 2 2 2 I 2 2 
capillary ingrowth I 2 2 2 2 2 0 0 
accumulation fibrous tissue 2 3 2 2 I I I 0 
0 refers to absence of lesion; 1 to mildest and 4 to most severe form of lesion. 
Table 4 
Histopathology of cardiac allografts. Group two. 
DLA typing Non-iden~ical 
Dog number B843 BD9118 BD9149 BD982 BD997 BD961 BD9202 B200 
Survival time (days) 9 10 11 11 14 17 44 48 
MYOCARDIUM: mononuclear infiltrate 2 2 3 1 3 2 
myocytolysis 2 2 3 1 3 2 1 1 
necrotizing arteritis 3 4 4 2 3 3 2 2 
focal necrosis 3 3 3 2 3 3 2 
rupture interstitial vessels 2 3 3 2 3 3 
CORONARY ARTERIES: 
(medium size) necrotizing arteritis 3 3 4 2 3 3 2 
obliterative arteritis 0 0 0 0 0 0 3 2 
VALVES: edema 1 2 2 2 2 2 
mononuclear infiltrate 1 2 2 2 1 2 3 2 
capillary ingrowth 0 0 0 0 0 0 
w 
accumulation fibrous tissue 0 0 0 0 0 0 1 0 'JO 
rig. 6: Right ventricular wall, showing features of acute rejection (see text); dog BD9118, survival 
time 10 days. HAS.X 200. 
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Fig. 7: Necrotizing arteritis in right vertricular wall, dog BD9118, survival time 10 days. HAS.X 
510. 
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Fig. 8: Portion of mitral valve showing mononuclear infiltrate and edema, dog BD9118, survival 
time 10 days. HAS.X 80. 
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Fig. 9: Medium sized coronary arteries, dog BD9173, survival time 132 days, showing obliterative 
arteritis. HAS.X 80. 
&3 
Fig. 10: Detail of medium sized coronary artery; dog BD9173, survival time 132 days: obliterative 
arteritis. HAS.X 200. 
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Fig.ll: Mitral valve of dog BD9173, graft survival time 132 days, showing mononuclear infiltrate, 
accumulation of fibrous tissue and collagen. HAS.X 80. 
45 
Fig. 12: Detail of mitral valve of dog BD 9173, graft survival time 132 days, showing capillary 
ingrowth into valve. HAS.X 80. 
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3.2. Second experiment. 
A total number of 13 orthotopic cardiac allotransplantations, without the 
use of homologous third party donor blood, were performed between 
randomly selected unrelated mongrel dogs, matched only for size and 
weight. The average body weight of the recipients was 11.5 kg. 
Excessive and uncontrollable blood loss from the aortic suture line caused 
the early loss of 3 dogs (23%). 
The I 0 surviving dogs returned to their normal activities until the process of 
acute allograft rejection became clinically apparent. At that time the animals 
became lethargic and lost their appetite. 
The dog sequence number, donor and recipient sex, survival times and post-
operative blood losses are listed in table 5. 
Postoperative blood loss averaged 797 ml among the 10 animals and ranged 
from 280 ml to 2604 mi. Disregarding the excessive amount blood loss of 
1300 ml and 2604 ml in two cases, the postoperative blood loss averaged 
500 ml among the other eight cases. 
For the ten surviving animals the mean survival time of 7.8 days (range of 
6 to 9 days) was observed. 
Table 5: Dog numbers, donor and recipient sex, survival times and postoperative blood loss. 
DOG NR. SEX OF SURVIVAL POSTOPERATIVE 
AND SEX DONOR TIME (DAYS) BLOOD LOSS (cc.) 
1 RH 163 M F 9 630 
2 RH 129M M 6 1300 
3 RH 176 M F 8 600 
4 RH 161 F F 8 420 
5 RH 164M F 8 840 
6 RH 152 M M 7 280 
7 RH 147 F M 7 380 
8 RH 136 F M 9 2604 
9 RH 153 F M 7 455 
10 RH 206 M F 9 460 
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On daily ECG recordings a progressive decrease in Q RS voltage, best seen in 
the R wave of limb lead II, was consistently found in all these dogs and 
preceded in every case the clinical signs of acute rejection. 
At autopsy, the histopathological findings for all I 0 grafts of the animals 
which recovered from surgery and subsequently died revealed the classical 
features of acute allograft rejection. 
Fig. 13, depicts the hemoglobin concentration of the recipients before and 
after transplantation. The mean hemoglobin concentration was 9,6 mmol/1. 
before starting the transplantation prodedure. The combined effect of 
transplant surgery with the use of the heart-lung machine, hemodilution 
and the technique for autotransfusion caused a decrease in the hemoglobin 
concentration to a mean value of 6,4 mmol/1. 
A minimum in hemoglobin concentration of 5.8 mmol/1 was found in the 
early postoperative period. Afterwards it gradually increased. 
HAEMOGLOBIN CONCENTRATION (mmol /1) BEFORE AND AFTER TRANSPLANTATION 
Hb 
(mmol /1) 
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Fig. 13: Hemoglobin concentration of the recipient dogs before and after transplantation, hemodi-
lution and autotransfusion. Mean ±standard error of the mean are given. 
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HEMATOCRIT BEFORE AND AFTER TRANSPLANTATION 
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Fig. 14: Hematocrit of the recipient dogs before and after transplantation, hemodilution and auto-
transfusion. Mean± standard error of the mean are given. 
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l'ig. 15: Platelet count of the recipient dogs before and after transplantation, hemodilution and 
autotransfusion. Mean± standard error of the mean arc given. 
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PLASMA FIBRINOGEN BEFORE AND AFTER TRANSPLANTATION 
FIDRINOGEN 
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Fig. 16: Plasma fibrinogen concentration of the recipient dogs before and after transplantation, 
hemodilution and auto transfusion. Mean± standard error of the mean are given. 
The same pattern for the mean hematocrit of the recipients is shown in Fig. 
14. Starting at a mean hematocrit of 46.7%, surgery and hemodilution 
caused a drop of the hematocrit to a minimum of 29 .I% and then started 
increasing gradually again. 
The platelet count before and after transplantation is demonstrated in 
Fig. 15 as measured by the Coulter counter technique. 
Before transplantation a mean platelet count of 206.5 x 109/L is found. 
A drop of 40% is the result of the transplantation procedure and technique 
of auto transfusion of a mean value of 123. x 1 o9(L. Also a further decrease 
is noticed during the first postoperative day after which day the platelet 
count increases again. 
Plasma fibrinogen concentrations are shown in Fig. 16. Before transplant-
ation a mean plasma fibrinogen concentration of 3.1 g/1 is found in the 
recipients. Immediately after surgery there is a drop to a mean value of 
1.3 g/1. However, during the first postoperative day the mean fibrinogen 
concentration increased to above pretransplant levels at 4.1 g/1. 
Fibrinogen degeneration products could never be demonstrated. 
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CHAPTER FOUR 
DISCUSSION AND CONCLUSIONS 
4.1. First experiment. 
The first objective of this study as formulated in chapter 1.3, has been 
accomplished. According to the results documented in the preceding 
chapter a prolongation of canine cardiac allograft survival can be 
repeatedly produced without the use of immunosuppressive treatment. 
DLA matching in sibs and prolongation of cardiac allograft survival. 
In the first chapter it is argued that both a prolongation of allograft 
survival and the absence of an immunosuppressive treatment are judged 
to be essential prerequisites in producing a canine model of chronic reject-
ion of a cardiac allograft. The term "chronic" merely indicates the import-
ance of a lapse of time to permit a slow development of the rejection 
process after allografting. This is in contrast to the process of acute allo-
graft rejection which, without appropriate treatment, will result in a short 
duration of allograft survival or, in the case of late acute rejection, when 
death of the animal ensues in a few days. 
The process of destruction of an allograft, i.e. the whole chain of events 
aimed at antigen localization, destruction and removal is only partly known 
(125); it is caused by the immune reaction of the recipient against the 
antigenic challenge of an allograft. The intensity of the unmodified immune 
reaction is determined by the antigeneticity of the graft and the intensity 
of the cellular and humoral immune response of the host. As a consequence, 
the differences in strong and weak transplantation or histocompatibility ant-
igens between donor organ and recipient influence the intensity of the 
immune reaction. 
Minimizing the disparity of these histocompatibility antigens between donor 
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organ and host tissue explains why DLA identity has a profound influence 
on graft survival if donor and recipient are siblings. Also a good match is 
accomplished for the other undefined gene products of the major histo-
Compatibility complex (102). 
As for the cardiac allograft (14, 96, 99), DLA matching in siblings has also 
been demonstrated by many transplantation experiments to influence 
graft survival, such as skin, kidney, small intestine, pancreas, lung, liver, 
bone marrow and frozen nerve (I, II, 12, 32, 98, 110, Ill, 112, 122, 123). 
The intensity of the immune reaction is also determined by presently un-
defined histocompatibility systems, other than the DLA histocompatibi-
lity complex (19, 120, 121 ). In other words, the present level of under-
standing the DLA-serology, does not necessarily signify the complete ab-
sence of incompatibility between donor and recipient. Therefore, DLA-
identity between donor and recipient siblings can not, by the presence of 
these minor histo-incompatibilities, prevent the ultimate rejection of a graft 
by its host. 
It has been demonstrated in mice that, where weaker histo-incompatibilities 
are involved between donor organ and host tissue, a greater variability in 
survival times is to be expected (I 04). In fact, this very likely is an 
important reason for the observation in group one of this study, where 
graft survival time ranges from 21 to 247 days (mean survival time: 96.6 
days). Accordingly, this could also explain the observation in the second 
group of DLA-nonidentical beagle littermates after cardiac allotransplant-
ation, that two long term survivors (respectively 48 and 44 days) and 6 
short term survivors (mean survival time: 12 days; range 9 to 17 days) 
were documented. 
A comparison of the survival times of different visceral organs after trans-
plantation is a difficult problem. Many factors are involved which could 
make a comparison invalid. These include differences in the antigenicity 
of the organs, the type of transplant surgery involved, the differences in the 
physiologic tasks of these organs and so on. Without taking these factors 
into account, it is remarkable that for instance the survival times for cardiac 
allografts documented in group one of this study, exceed those of kidney 
allografts between DLA-identical sibs (mean survival time 43.0 days). These 
data have been reported by Westbroek eta!. from the same laboratory (123). 
This disparity in survival times between the two transplanted organs could 
be explained by a beneficial effect of the liberal use of third party donor 
blood in cardiac allografting during the operative period. Homologous 
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donor blood was not administered to the recipients of the kidney trans-
plants. This interesting aspect of allografting stresses again the urgent need 
to develop a suitable model for orthotopic heart transplantation in dogs 
without the use of homologous blood. 
Donor-recipient incompatibilities for Swisher erythrocyte antigens (113) 
were not taken into account in our study. However, the results of Rappaport 
eta!. (99) did not show direct evidence that such incompatibilities had an 
adverse influence upon the duration of cardiac allograft survival in tissue 
typed beagle littermates. 
A detailed discussion on the many factors that influence the immune res-
ponse of a recipient against its allograft is beyond the scope of this study. 
However, the occasional finding of a prolongation of survival time in pup-
pies after cardiac allotransplantation without the use of immunosuppres-
sive drug should be mentioned. 
A survival time of 150 days after orthotopic heart transplantation between 
littermate puppies has been reported by Hurley and Kosek (61 ), but they 
stated that no tissue typing of donor and recipient was performed. DLA-
identity of donor and recipient could have explained this result. 
Kondo eta!. (65, 66) documented two long term survivors after orthotopic 
heart transplantation in puppies. Donor and recipient were unrelated. 
Neither dog received immunosuppressive treatment. One animal was well 
and alive 112 days after surgery at the time of report and the other dog 
survived 57 days. 
Although the authors state that these results may be explained by 
"unpredictable" histocompatibility, they also express the belief that young 
animals tolerate allografts better than adults. 
For kidney transplants Claman eta!. (33) reported one long term survivor 
of 68 days in II experiments after allografting from a mongrel puppy to 
an unrelated adult mongrel dog. They suggest that the concept of using 
"immature" tissue needs further exploration. 
The electrocardiogram and cardiac allograft survival. 
The arrhythmias, present during the early postoperative phase are very 
likely the result of surgical trauma, the use of topical hypothermia for pre-
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servation of the heart during the surgical procedure and the period of 
anoxic arrest in itself. 
The arrhythmias receded spontaneously without producing obvious alter-
ations in the clinical status of the animals. These transient arrhythmias 
are unlikely to be related to any type of the rejection response by the host 
against the cardiac allograft. 
Many experimental and clinical studies have shown a relationship between 
the late occurence of electrocardiographic abnormalities and the patholo-
gical changes in the transplanted heart during the course of the rejection 
process (47, 80, 109). Above all, a decrease in the QRS voltage proved to 
be the most consistent and an early sign of the acute rejection process, 
usually beginning four to five days prior to the death of the recipient (80 ). 
Unless immunosuppressive drugs are given, the decrease in the QRS voltage 
is progressive during the final course of acute rejection (47, 79). In clinical 
practice this close correlation between a decrease in the QRS voltage and 
the presence of acute rejection could be verified by the method of taking 
endomyocardial biopsies (27, 49). 
The cardiac conduction system is as vulnerable to immunologic damage as 
the other tissues of the heart, but at present, the most likely primary factor 
to explain this phenomenon of a drop in the QRS voltage is the progression 
of myocardial edema during the acute rejection process (I 0). 
The follow-up studies of the short term surviving dogs in group one and 
group two confirm these observations: 
I. the QRS voltage drop was the most consistent finding in the short survi-
ving dogs in both groups. 
2. it was not observed in the long term surviving animals in both groups. 
3. it correlated well with the histopathological findings of acute cardiac 
allograft rejection. 
4. in every instance there was a short time interval between the first recor-
ding of this electrocardiographic abnormality and the time of death of 
the animal. 
The initial electrocardiographic changes observed in the long term surviving 
dogs were arrhythmias, mainly consisting of conduction disturbances. In all 
instances these were followed by a prolonged time interval between the 
initial recording of the electrocardiographic abnormality and the time of 
death of the animal as compared to the short time interval in the case of 
acute rejection. 
54 
The problem of explaining these arrhythmias and the prolonged time interval 
between their first recording and the time of death of the animal was not 
explored in this study. Certainly, it can be postulated that progressive ische-
mic damage to the myocardium and the cardiac conduction system, as the 
result of the vascular lesions observed in the graft, is a major cause. At least 
it signifies that irreversible and localized damage t.::J the myocardium has 
occurred. The method of taking serial myocardial biopsies (9 5), which was 
not used in this study, could be expected to contribute to the detection of 
the "point of no return" of these lesions. 
Histopathology and cardiac allograft survival. 
The predominant histopathological feature of chr0nic cardiac allograft re-
jection is to be found in the larger medium sized vessels of the graft and is 
indicated as chronic obliterative arteritis. This was repeatedly found in the 
grafts of the long term surviving animals of group one and in the two long 
surviving animals of group two. This observation could be convincingly 
confirmed by the "blind" assessment technique in grading the lesions by an 
independent investigator. 
He also confirmed the observation that the obliterative vascular lesions 
were never observed in the grafts of the short term surviving animals. 
Three dogs, Bd 9219 in group one and Bd 9202, B 200 in group two 
(tables 3 and 4, page 38, 39) demonstrated both types of vascular lesions, 
i.e. necrotizing and obliterative arteritis. 
Observing the extremes and the inbetweens of the dogs in group one and 
group two brought together in one serie, then there is obviously a complete 
spectrum of lesions. Lesions of the parenchymal type are most promiment 
in the shortest surviving animals, an overlap of parenchymal and vascular 
lesions occurs in the middle and the obliterative vascular lesions are the 
most prominent features in the long term surviving animals. 
Concentrating on chronic obliterative arteritis as the prominent lesion in 
this model of chronic rejection of the orthotopic canine cardiac allograft, 
the possible explanations for the mechanism causing this lesion should be 
discussed. 
A spectrum of lesions, as observed in the whole serie of dogs in group one 
plus group two, favors the concept of quantitative differences in the immu-
ne response of the hosts. The severity of the vascular lesions parallels the 
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duration of graft survival and therefore also favors the concept of quantita-
tive differences. 
As prolongation of graft survival resulted from DLA matching, it is there-
fore unlikely to be the result of qualitative changes in the host immune 
response. 
Adequate immunosuppressive treatment of acute rejection episodes in a long 
term surviving dog produces the same type of lesions typical of chronic 
rejection in the graft as has been reported by many investigators (68, 69, 
70. 75). 
These arguments all support the concept that chrodc rejection of a cardiac 
allograft from a DLA-identical donor in this model is most likely explained 
by quantitative rather than by qualitative changes in the humoral and cellu-
lar immune response of the recipient. 
It is postulated that the humoral or antibody-mediated immune response is 
mainly responsible for these vascular lesions (73, 92, 117, 124 ). 
The intensity of this part of the immune response does not necessarily have 
to be of the low grade type, but its typical features can be accentuated by a 
low grade course of the cell-mediated immunologic injury over a long period 
of time. 
The precise mechanism of the humoral immune response causing the vascu-
lar lesions is still much debated. Even a certain synergism between the humo-
ral and cellular components can not be excluded (I 04 ). 
Based on an analysis of the cell specificity of the antibody response in hu-
man kidney allograft rejection, Cerelli eta!. (29, 30) postulated that histo-
compatibility antigens are found on the vascular endothelial cells, but they 
also contain antigen not found on renal cells or lymphocytes. It is their 
opinion that this antigen is important in the pathogenesis of the vascular 
lesions in a graft. 
It has also been shown that during the rejection process there is a deposi-
tion of antigen-antibody complexes in the vascular wall (59, 62, 82, 97). 
These immuno-complexes are supposed to damage the intima of the small 
vessel wall by provoking platelet aggregation. 
0' Connell and Mowbray (91) succeeded in provoking such arterial intima 
lesions in rabbits. 
Kosek eta!. (70) have suggested a unifying hypothesis to explain the simi-
larity between chronic obliterative arteritis and spontaneous arterioscle-
rosis. They state that the primary immune damage to the vasa vasorum of 
the arteries leads to medial hypoxia. Also there is an immune damage direct 
to the endothelial cells of the arteries. The whole process results in a sub-
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endothelial accumulation of myointimal cells which migrate inward to res-
tore the damaged endothelial surface of the arteries. 
The Valvular lesions, as they are described in this study and observed in the 
long term surviving animals were also reported by Hurley et al. ( 61) in one 
dog surviving 5 months without immunosuppressive treatment. 
Kosek et al. (68) reported segmental replacement by hyaline scleroprotein 
in the valves in four out of 12 dogs surviving 2 months or longer with immu-
nosuppressive treatment. 
Leandri-Cesari et al (75) described thickening and irregularities of the free 
edges of the valves in a dog surviving seven years after orthotopic heart 
transplantation. However, the authors did not report on the microscopic 
features of the valves. 
Bieber et al. (1 0), in their article on cardiac allograft pathology in man, 
mention a mild degree of mitral and tricuspid subvalvular fibrosis in the two 
oldest specimens. 
It can be postulated that the valvular lesions observed in this study are 
basically the result of the humoral or antibody-mediated immune response 
of the host as it is also responsible for the vascular lesions in the graft. 
In general, it is obvious that the histopathological changes of chronic re.-
jection represent essentially an irreversible state of rejection. Because no 
immunosuppressive drugs were employed and no late acute rejection was 
superimposed in this model of chronic rejection, the orthotopic canine 
cardiac allograft from a DLA-identical donor can be used as a standardized 
model of chronic rejection. At least three applications are apparent. 
1. To study the course and the characteristic features of chronic rejection 
in more detail. Our study did not document the sequential histologic 
events as they occur in the cardiac graft. 
No helpful! parameters for monitoring the early onset of the observed 
changes emerged from our study. 
Studies have been undertaken in our laboratory and reported by Penn 
et al. (96) to enlighten these aspects of chronic rejection in this canine 
model. 
2. To study the aspecific suppression of the immune response by the ad-
ministration of drugs during the course of chronic rejection in a standard-
ized model, not superimposed by early or late acute rejection. The same 
holds for the study of specific suppression of the immune response, for 
example, studies on enhancement of the cardiac allograft in this model. 
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3. To study the possible influence (48, 73) on the progress of the character-
istic arterial intimal changes during chronic rejection or to prevent their 
occurrence by treating the recipient with anticoagulants or a well balan-
ced diet. 
Accepting Kosek's unifying hypothesis, such a study could contribute 
to a large extent to our knowledge of spontaneous arteriosclerosis. 
The most important shortcoming of this study has been the use of homolo-
gous third party donor blood during the surgical procedure and post-
operative course in this first experiment. The relevance of blood transfu-
sions has already been mentioned and will be included in the discussion on 
the results of the second experiment. 
4.2. Second experiment. 
The results presented in chapter 3.2 clearly demonstrate the technical feasibi-
lity of performing orthotopic canine cardiac allotransplantation without ad-
ministering third party donor blood to the recipient. In spite of the low 
average weight of the recipients (11.5 kg), the methods of total hemodilu-
tion and auto transfusion proved to be adequate to achieve a survival rate of 
77%. 
The choice of small sized mongrel dogs in this study was made to enable the 
planning of new transplantation experiments in relatively small sized but 
more costly beagles. This is in accordance with the general tendency to 
standardize the choice of the experimental dog in transplantation experi-
ments to make the comparison of the results more meaningfull. To this end 
the small sized beagle is more and more the animal of choice and is used 
nowadays in many laboratories (I, 2, 85, 115). 
The surgical mortality of 23% in this experiment was even less than the 29% 
observed in the first experiment. However, it is premature to conclude from 
these data that total hemodilution and postoperative autotransfusion is 
superior to the use of third party donor blood. 
There has been a notable time gap between the performance of the surgical 
procedures of the two experiments. Undoubtedly a gain in experience 
contributed a great deal to the disparity in surgical mortality between the 
two experiments. Nevertheless, the friable supravalvular aortic tissue again 
was the most challenging problem of the surgery. 
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There is still much debate about the optimal amount of hemodilution in 
clinical practice. The opinions diverge from a complete blood priming of the 
heart lung machine to non-blood priming or so called total hemodilution 
(36, 41, 126). 
The low hemoglobin levels resulting from total hemodilution could endanger 
the myocardium by producing ischemia. Brazier et a!. (16) demonstrated 
that in anesthetized dogs with normal coronary arteries, coronary bloodflow 
remains normally distributed and myocardial oxygen delivery is adequately 
maintained with moderately severe levels of normovolemic anemia, i.e. 
hemoglobin concentration above 3.0 mmol per liter. 
Such a low level of hemoglobin concentration was never reached in our 
experiments. 
Mullerworth et a!. (86) have reported a study on the use of HAEMACCEL ~ 
a degraded and repolymerized bovine gelatin, for total pump prime during 
60 minutes of cardiopulmonary bypass in five dogs weighing 18 to 23 kg. 
No major surgery was performed and no blood transfusions were administ-
ered. All animals survived the procedure, appeared healthy and no lasting 
ill effects were detected. By measuring clotting time, partial thromboplas-
tin time, prothrombin time, and euglobulino1ysis they observed a slight 
decrease in clotting efficiency which was demonstrated most clearly by the 
partial thromboplastin time. Gross clotting disturbances were also not ob-
served in our experiments, even though major surgery was added to the 
procedure. 
The idea of auto transfusion first came into history for a quite different 
reason than it was used in this experiment. The first autotransfusion can 
be traced back to the beginning of the last century (3 ). 
To salvage the loss of shed blood and not having the opportunity this loss 
to be replaced by donating homologous blood transfusions, the obvious 
solution was autotransfusion. With the development of blood banks it be-
came an obsolete procedure until the last decade when interest has increased 
again for the use of this technique in the treatment of patients with massive 
bleeding. Numerous articles, mainly on intraoperative autotransfusion, have 
since then appeared. At least nine different autotransfusion devices have 
been evaluated experimentally and clinically (84). The first autotransfusion 
seminar was organized by Brawly and Hauer at the John Hopkins University 
School of Medicin, Baltimore, in April 1978 (15). 
Intracardiac surgery, routinely employing cardiopulmonary bypass, is 
completely dependent on the principles of intraoperative autotransfusion. 
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The complexity of the hematological problems involved are tremendous 
and many aspects of it are still unexplained. 
The most recently devised technique of auto transfusion for the utilization 
of spilled blood in closed cavities during the postoperative period is less com-
monly used however. 
Symbass recently (114) reported on the effect of autotransfusion upon the 
blood components and the recipient. In dogs he connected a pleural space to 
a femoral artery with a plastic tubing and a chest tube was inserted into the 
pleural space. With the chest tube clamped, one quarter of the dog's blood 
volume was allowed to bleed into the right pleural space. No ACD-drip by 
an infusion line into the pleural space was used. After autotransfusion from 
the collecting bottle, he found no changes in the dog's bleeding and clot-
ting times. The hematocrits of the blood drawn from the hemothorax were 
significantly lower than that of the control arterial blood. Platelets and 
plasma fibrinogen decreased or almost vanished from the hemothorax. 
However, after autotransfusion, both parameters were at or above the 
control arterial levels. He postulated that the trapping of red cells by 
intrathoracic clot formation and the defibrinating mechanical action of the 
lung and heart were the major causes of the decrease in hematocrits, plate-
lets and plasma fibrinogen. Because of these low values it is ve,-y likely that 
the blood from the hemothorax did not clot. On the next day the plasma 
fibrinogen concentration was above baseline level. He assumed that the 
occurrence of hemolysis as a result of the autotransfusion technique, ex-
plained these high levels of plasma fibrinogen. However, it has also been 
stated (9) that the body is able to compensate fully for the deficiency in 
plasma fibrinogen. 
The important advantage of this technique of autotransfusion is that 
anticoagulation does not have to be employed. In our experiment we added 
an infusion line for a continuous ACD-drip into the thoracic cavities, as has 
been practiced by other investigators (18). This is supposed to prevent clot 
formation in the chest and allows the optimal use of the shed blood. 
In general, our data on hemoglobin concentration, hematocrit, platelet 
count and plasma fibrinogen are in accordance with the data reported by 
Symbass. The below normal levels of hemoglobin concentration, hematocrit 
and platelet count found after surgery are well explained by the low values 
in the autotransfusion blood which is centrifugated and returned to the re-
cipient as packed cells. The waste of blood during the transplant surgery, 
which also includes the use of the non-blood primed heart lung machine 
contributed to this. The elimination of the hemolytic plasma by centrifuga-
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tion of the collected blood, did not prevent the occurrence of above normal 
values in plasma fibrinogen as measured on the second postoperative day. 
Fibrinogen degeneration products could never be demonstrated in the auto-
transfused recipients. This observation is also in accordance with data report-
ed in literature (9). 
The results demonstrate that an average postoperative blood loss of 500 ml, 
which is more than half of the estimated mean blood volume of 900 ml in 
these dogs, can be successfully handled by autotransfusion. Even the 
excessive amount of shed blood in two instances, 1300 and 2600 ml respect-
ively, could be effectively managed by this simple method. 
After surgery the animals showed normal activities comparable to the ani-
mals in the first experiment. However, it should be mentioned that they 
were limited in physical activities by their cages and were not submitted to 
any type of stress test. 
Acute rejection of the graft was heralded by a progressive decrease in the R 
wave of limblead II in all cases and preceeded the clinical signs of lethargy 
and anorexia. 
The histopathological graft findings demonstrated the typical features of 
acute cardiac allograft rejection. These findings did not reveal any differ-
ences compared to the histopathology of the acute rejected grafts in the 
series of orthotopic heart transplants performed in unrelated mongrels, 
with the use of third party donor blood published by Jongsma (63). 
The topic of blood transfusion and transplantation has been recently 
overviewed by van Rood and Bainer and by Morris (I 03 ). 
The issues at stake are, on the one hand a proven detrimental effect (64) 
and on the other hand, a claimed beneficial effect of blood transfusions 
on the prognosis of graft survival (60, 94). The article of Opelz et all. (93) 
triggered the discussions on this topic. They reported that patients, not 
having had pretransplant blood transfusion, fared worse than patients that 
did receive blood transfusions before the kidney transplant was inserted. 
At about the same time Coulson et al. (39) formulated the effect of previous 
blood transfusion on graft prognosis in clinical heart transplantation from 
the opposite point of view. They stated "It appears that patients who have 
had previous heart surgery on (cardio-pulmonary) bypass fare better with their 
heart transplant than those who have not had surgery". It is suggested by 
these authors that serum factors are produced in the patient and inhibit or 
depress lymphocyte responsiveness in vitro. The nature of these serum 
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factors is not clear but when added to mixed lymphocyte cultures these 
sera exerted an inhibitory effect. To these authors there appeared to be a 
correlation between transplant survival and the presence of serum immune-
depressive factors. 
In kidney transplantation it is discussed that blood transfusions could 
distinguish between those patients with an intense immune response (res-
ponders) and those with a reduced immune response (nonresponders) 
(17,19). 
In rodents the beneficial effect of the administration of blood on graft 
prognosis prior to transplantation has been reported some years ago by 
Marquet et a! (83 ). Other experiments in different species like dogs and 
monkeys (46, 90) have been reported to favor a beneficial effect of pre-
transplant transfusions. 
In general all investigators, interested in this aspect of organ transplantation, 
admit to a lack of complete knowledge about the precise mechanism that 
causes a favorable influence on graft prognosis on the one hand and an 
acceleration of graft rejection on the other hand. 
According to Obertop (90) a definite favorable influence on canine kidney 
graft prognosis is observed when pretransplant third party blood transfu-
sions are combined with the use of immunosuppressive drugs after surgery. 
It is tempting to compare the observed survival times in this second experi-
ment (mean survival time 7.8 days; S.D. ± 1.0) as presented in table 5 
with the observed survival times reported by Jongsma (63). In his serie of 
13 unmodified orthotopic cardiac allografts in unrelated mongrels the acute 
rejection response resulted in the following survival times: respectively 5, 5, 
5, 6, 9, 9, 10, 10, 10, II, 15, 15,15 days (mean survival time 9.6 days; 
S.D.± 3.7). 
A comparison of the two series appears to be appropriate because all trans-
plant procedures in both series were performed according to the same surg-
ical technique and by the same surgical team. Assuming the validity of 
comparing the two series while no data on DLA matching are available, the 
major disparity between the two series is the use of third party donor blood. 
There is no statistically significant difference between the mean survival 
times of the two series. 
In Fig. I 7 the comparison of these two series is depicted graphically by the 
survival curves of the grafts in these two series. This figure suggests an 
influence of the use of homologous donor blood on the outcome of an 
orthotopic canine cardiac allograft, in the sense that the administration of 
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donor blood tends to prolong graft survival time in a number of dogs. Out 
of 13 dogs in the serie of Jongsma 7 animals (54%) lived I to 5 days longer 
than the longest survivor of 9 days in the serie of our second experiment. 
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Fig. 17 Orthotopic cardiac allograft survival in 13 mongrel dogs with the use of homologous donor 
blood (B) and 10 mongrel dogs without the use of homologous donor blood (NB). 
Certainly prospective experiments with regard to the effects of third party 
donor blood on graft prognosis in orthotopic cardiac transplantation in 
well controlled studies have to be performed. This has been the very reason 
to formulate and to undertake the second objective of the present study. 
This model of orthotopic canine cardiac allografting without the use of 
homologous donor blood is now available and enables the design of 
experiments in well controlled studies. Schemes of pretreatment of the 
recipient with whole blood or blood components to study the effect on 
the outcome of an orthotopic cardiac allograft are now within reach. 
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The Hatter was the first to break the silence. 
"Have you guessed the riddle yet?" he asked. 
"No, I give it up", Alice replied: "what is the answer?" 
"I haven't the slightest idea", said the Hatter. 
"Nor I", said the March Hare. 
A MAD TEA-PARTY. 
Alice in Wonderland. 
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SUMMARY 
In the first part of Chapter One it is argued that progress with regard to long 
term results in experimental and clinical heart transplantation is limited by 
the late development of graft arteriosclerosis. This is the result of an insidu-
ous, slowly developing process of chronic rejection. In contrast to acute 
rejection, the histopathological changes occurring in the vasculature of the 
cardiac allograft during chronic rejection proved to be progressive and not 
amenable to be reversed by the use of high dosages of the presently available 
immunosuppressive drugs. So far, only precautionary measures like the ad-
ministration of anticoagulants and the prescription of dietary restrictions 
to the heart transplant patient are claimed to be used with some success 
against the process of chronic rejection. 
It is concluded that, to enable the study in more detail of the ongoing 
events during chronic rejection, a search for a suitable model in canine 
orthotopic cardiac allografting should be undertaken. 
In the rationale of the study (paragraph 1.2) the arguments are presented 
that preferable such a model should not be influenced by the detrimental 
effects of immunosuppressive drugs. It also reasoned that the use of homo-
logous third party donor blood during transplant surgery and thereby its 
influence on graft prognosis must be taken into account. 
In paragraph 1.3 the objectives of the study are formulated as follows: 
The first objective was to develop a model of chronic rejection of an 
orthotopic canine cardiac allograft using DLA-identical beagle littermates 
without immunosuppressive drugs. 
The second objective was to design and test a surgical technique of ortho-
topic cardiac transplantation without the need for homologous donor 
blood. 
In Chapter Two the data, relevant to the material and methods used in this 
study, are presented and is followed by the documentation of the results in 
the Third Chapter. 
These results demonstrate that without the use of immunosuppressive drugs, 
DLA-identity between donor and recipient beagle siblings after orthotopic 
heart transplantation provides the characteristic histopathological feature 
of chronic rejection, indicated as chronic obliterative arteritis. 
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Paragraph 3.2 of the Third Chapter documents the technical feasibility of 
performing orthotopic canine cardiac allotransplantation without the use of 
homologous third party donor blood. 
In the first part of Chapter Four the obtained canine model of chronic 
rejection of an orthotopic heart transplant is discussed and a number of 
applications for its use are mentioned. 
The second part of Chapter Four comprises a more detailed discussion on 
the use of total hemodilution and autotransfusion for successfull ortho-
topic heart transplantation in a small sized dog. 
Finally, after a brief discussion on the relationship between blood trans-
fusions and transplantation, a tentative comparison is made between the 
survival times of the ten dogs observed in the second experiment with the 
survival times of thirteen dogs operated in the past by the same surgical 
team under comparable circumstances but with the liberal use of homolo-
gous donor blood during transplant surgery. This comparison suggests that 
the administration of homologous third party donor blood during trans-
plant surgery tends to prolong graft survival time. 
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SAMENVATTING. 
In de eerste paragraaf van Hoofdstuk I wordt getracht duidelijk te maken 
dat een verbetering van de resultaten op langere termijn bij de experimente-
le en klinische harttransplantatie gehinderd wordt door het late optreden 
van arteriosclerose in het transplantaat. 
Dit is het resultaat van een zich geleidelijk ontwikkelend proces van chron-
ische transplantaat afstoting. De histopathologische veranderingen, welke op-
treden in het vaatstelsel van het harttransplantaat gedurende de chronische 
afstoting blijken, in tegenstelling tot de afwijkingen bij de acute transplan-
taat afstoting, progressief te zijn ondanks het gebruik van immunosuppres-
siva en niet reversibel bij hogere doseringen van deze medicament en. Alleen 
de toediening van anticoagulantia en het voorschrijven van dieet maatrege-
len zijn tot op heden met enig succes toegepast tegen het optreden van de 
chronische transplantaat afstoting. 
Om een meer gedetailleerde bestudering van de gang van zaken bij de chron-
ische transplantaat afstoting mogelijk te maken, wordt geconcludeerd dat 
er gezocht moet worden naar een hiertoe geeigend model van orthotope 
harttransplantatie. In de Paragraaf 1.2 wordt aangetoond dat bij voorkeur 
een dergelijk model niet belnvloed dient te worden door de nadelige bij-
werkingen als gevolg van de toediening van immunosuppressiva. Tevens 
wordt besproken dat het gebruik van homoloog donor bloed tijdens de 
transplantatie procedure van invloed kan zijn op de prognose van het 
transplantaat en daarom van belang geacht moet worden bij de beoordeling 
van de resultaten. 
In Paragraaf 1.3 worden de doelstellingen van dit onderzoek als volgt gefor-
muleerd: 
De eerste doelstelling is geweest het ontwikkelen van een model van chron-
ische afstoting van een orthotoop harttransplantaat bij de hand door ge-
bruik te maken van DLA-identieke beagles uit hetzelfde nest en zonder de 
toepassing van immunosuppressiva. 
De tweede doelstelling is geweest de mogelijkheid te onderzoeken of een 
orthotope harttransplantatie uitgevoerd kan worden zonder dat hierbij ge-
bruik gemaakt wordt van homoloog donor bloed. 
In het Tweede Hoofdstuk zijn de gegevens vastgelegd met betrekking tot 
het gebruikte materiaal en de gevolgde method en. 
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De resultaten van dit onderzoek zijn gedocumenteerd in het Derde Hoofd-
stuk. Uit deze gegevens blijkt dat na orthotope harttransplantatie en zonder 
de toepassing van irnmunosuppressiva, identiciteit voor het DLA histocom-
patibiliteits complex tussen donor en ontvanger bij beagles afkomstig uit het-
zelfde nest, resulteert in het kenmerkende histologische beeld van de chron-
ische transplantaat afstoting, welke wordt aangeduid als chronische oblite-
rative arteritis. 
In paragraaf 3.2. wordt aangetoond dat het technisch mogelijk is een ortho-
tope harttransplantatie bij de hond uit te voeren zonder daarbij gebruik te 
maken van homoloog donor bloed. 
In het eerste dee! van Hoofdstuk Vier wordt het verkregen model van de 
chronische afstoting van een orthotoop harttransplantaat bij de hond be-
sproken en worden een aantal mogelijkheden voor verder onderzoek met 
behulp van dit model verrneld. 
Het tweede dee! van Hoofdstuk Vier bevat een meer uitgebreide discussie 
over de toepassing van hemodilutie en autotransfusie bij de orthotope hart-
transplantatie, met name bij kleine honden. 
Na een korte bespreking van het verband tussen de toediening van bloed-
transfusies en transplantatie, worden tenslotte de levensduur van de 10 hon-
den na transplantatie uit het tweede experiment vergeleken met de levens-
duur na transplantatie van 13 honden we1ke in het verleden door hetzelfde 
chirurgische team en onder dezelfde omstandigheden werden geopereerd, 
maar met het gebruik van homoloog donor b1oed. 
Op grond van deze vergelijking is het zeer waarschijnlijk dat de toediening 
van homoloog donor bloed tijdens de transplantatie procedure van invloed 
is op de prognose van het harttransplantaat. 
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